Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer

Author： Brunsvig Paal   Aamdal Steinar   Gjertsen Marianne   Kvalheim Gunnar   Markowski-Grimsrud Carrie   Sve Ingunn   Dyrhaug Marianne   Trachsel Sissel   Møller Mona   Eriksen Jon   Gaudernack Gustav  

Publisher： Springer Publishing Company

ISSN： 0340-7004

Source： Cancer Immunology, Immunotherapy, Vol.55, Iss.12, 2006-12, pp. : 1553-1564

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Personalized peptide vaccination in patients with refractory non-small cell lung cancer

By                        

International Journal of Oncology, Vol. 40, Iss. 5, 2012-01 ,pp. : 1492-1500

Spandidos Publications

Access to resources Recommend Favorite

Gemcitabine and paclitaxel associated pneumonitis in non-small cell lung cancer - report of a phase I/II dose-escalating study

By Thomas A.L.   Cox G.   Sharma R.A.   Steward W.P.   Shields F.   Jeyapalan K.   Muller S.   O'Byrne K.J.  

European Journal of Cancer, Vol. 36, Iss. 18, 2000-12 ,pp. : 2329-2334

Elsevier

Access to resources Recommend Favorite

Phase II study of XR 5000 (DACA), an inhibitor of topoisomerase I and II, administered as a 120-h infusion in patients with non-small cell lung cancer

By Dittrich C.   Coudert B.   Paz-Ares L.   Caponigro F.   Salzberg M.   Gamucci T.   Paoletti X.   Hermans C.   Lacombe D.   Fumoleau P.   on behalf of the European Organization for Research and Treatment of Cancer-Early Clinical Studies Group/New Drug Development Programme EORTC-ECSG/NDDP  

European Journal of Cancer, Vol. 39, Iss. 3, 2003-02 ,pp. : 330-334

Elsevier

Access to resources Recommend Favorite

Pre-operative Chemoradiotherapy in Non-small Cell Lung Cancer Stage III Patients. Feasibility, Toxicity and Long-term Results of a Phase II Study

By Favaretto A.   Paccagnella A.   Tomio L.   Sartori F.   Cipriani A.   Zuin R.   Reffosco L.   Calabro' F.   Rea F.   Ghiotto C.   Chiarion-Sileni V.   Oniga F.   Loreggian L.   Fiorentino M.V.  

European Journal of Cancer, Vol. 32, Iss. 12, 1996-11 ,pp. : 2064-2069

Elsevier

Access to resources Recommend Favorite

Phase II Trial of Docetaxel in Asian Patients with Inoperable Stage III Non-Small Cell Lung Cancer

By Goh Boon C.   Lehnert Manfred   Lim Hong L.   Ng Alan W. K.   Chan Choong C.   Kong Hwai L.   Lee Soo C.   Wee Joseph   Chua E. T.   Wong John E. L.  

Acta Oncologica, Vol. 39, Iss. 2, 2000-08 ,pp. : 225-229

Informa Healthcare

Access to resources Recommend Favorite